Search
Brachytherapy Improves Outcomes for Cervical Cancer Patients
Patients with locally advanced cervical cancer who receive chemoradiation therapy and brachytherapy and complete treatment within eight weeks have a superior overall survival rate compared to those who don’t receive this treatment, according to a UCSF study.Muscle Invasive Bladder Cancer
With at least one-quarter of bladder cancer patients presenting with deadly muscle-invasive tumors, decisions on staging and treatment are profound – yet must be made swiftly.First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 clinical trial.Cerebral Cavernous Malformation Treatments Relieve Disparate Symptoms
Two patients with severe yet different neurological symptoms were referred to UCSF for emergent neurosurgical evaluation. Both were found to have previously undiagnosed cerebral cavernous malformations (CCMs), but each patient’s treatment was unique.Radioligand Therapy Plus Pembrolizumab May Benefit Patients with Advanced Prostate Cancer
Immune checkpoint inhibitors have demonstrated limited efficacy in treating prostate cancer. Efforts to improve outcomes with combination therapies have mostly failed to demonstrate improvements compared to other types of cancer.Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer
Tumor Immune Microenvironments May Provide Clues to Future TherapiesTreating Severe Depression with On-Demand Brain Stimulation
UCSF Health physicians have successfully treated a patient with severe depression by tapping into the specific brain circuit involved in depressive brain patterns and resetting them using the equivalent of a pacemaker for the brain.New Practice Guidance on Malnutrition, Frailty and Sarcopenia in Patients With Cirrhosis, Led by UCSF Researcher
The first-ever American Association for the Study of Liver Diseases (AASLD) Practice Guidance on the management of malnutrition, frailty and sarcopenia in patients with cirrhosis is now available.UCSF Health Cancer Services Earns National Accreditation from the Commission on Cancer of the American College of Surgeons
The UCSF cancer program has been continuously accredited by the CoC since 1933, demonstrating its commitment to the best outcomes possible for its cancer patients.Fresh Insight on Cataracts: An Update on Evaluation and Management
Optometrist Emily Eng, OD, MS, FAAO, starts with a refresher on eye anatomy and the factors that make lenses get cloudy, then describes what patients want to know about cataract surgery (the most performed procedure in all of medicine), including pre- and post-op care.Advances in Obesity Medicine: Better Bariatric Surgery Options and Outcomes
With obesity affecting 40% of the U.S. population, bariatric surgeon Jonathan Carter, MD, reviews the devastating health effects of excess body fat and contends that clinicians can no longer sidestep difficult conversations about weight management.UCSF Research Vital to First Drug for Deadly Bone Disease
The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation in place of soft and connective tissues.UCSF Health Joins Registry to Improve Cardiogenic Shock Treatment
UC San Francisco’s Heart and Vascular Center has been recognized by The American Heart Association (AHA) for its participation in a new Cardiogenic Shock Registry.Personalized Therapy for Early-Stage Lung Cancer at UCSF
Follow the journey of a UCSF patient with early-stage, high-risk lung cancer, from history to treatment and prognosis, including how surgeons chose to do a robotic assisted VATS lobectomy and an analysis of how well chemo is likely to work for her.Deadly Dust: Engineered Stone Is Making California Workers Sick
Workers making artificial-stone slabs for the most popular type of countertops sold in the United States are developing a potentially deadly, irreversible lung disease from tiny particles of toxic dust, researchers from UC San Francisco and UCLA found...Guide to Early Pregnancy Problems: How to Explain Options and Navigate Discussions
In early pregnancy, common issues range from bleeding to ectopic attachment to miscarriage, and patients need accurate information and gentle guidance. Here’s help with delivering news and sharing decisions, including how to answer questions on specific management choices and whether a problem now signifies future pregnancy difficulties.Headache Update - Module 1
Our headache expert summarizes, simplifies and lists on-screen the primary headaches defined by the International Classification of Headache Disorders, including migraine, tension-type, cluster, and exertional headache, and introduces three case studies.New Complex Neurology Program Focuses on Hard-to-Diagnose Cases
In an effort to find answers to some of the most daunting neurological puzzles frustrating patients and clinicians alike, UC San Francisco has opened the Jan and Maria Manetti Shrem UCSF Neurology Complex Diagnosis Clinic, an innovative multidisciplinary center that tackles these issues head-on.Telehealth Referral Leads to Diagnosis and Effective Treatment of Rare Neuropathy: Case Study
A 68-year-old man from Hawaii with acetylcholine receptor (AChR) antibody–positive myasthenia gravis and poorly controlled type 2 diabetes complicated by neuropathy had been receiving intravenous immunoglobulin (IVIg) and taking pyridostigmine for two years when ...Updates from the American Society of Clinical Oncology (ASCO) 2017
A June 2017 Bay Area Breast Cancer Forum discussion of updates from the ASCO annual meeting, covering PARP inhibitors, germline BRCA mutations, HER2-positive cancer, patient-reported outcomes, immunotherapy and more. Moderator: Dr. Hope RugoNew Research Linking Type 1 Diabetes to Genetic Mutations May Lead to Precision Medicine
UCSF researchers have discovered specific genetic mutations that can cause type 1 diabetes. This groundbreaking work could result in effective precision treatments for patients.Keep Diabetic Patients on Their Feet: Keys to Identifying Limb-Threatening Issues
In a country where more than 9% of adults have diabetes, Alexander Reyzelman, DPM, discusses the implications for those who also have peripheral vascular disease.Subfertility in Male Patients: A Specialist Illuminates Diagnosis and Care
Reproductive urologist James F. Smith, MD, MS, discusses the wide range of causes for male fertility problems, from structural abnormalities, such as varicocele, to lifestyle factors, such as tobacco use, to hormonal issues, which can arise from use of common medications and supplements.Are New Therapies on the Horizon for Painful Skin Condition?
UCSF Health leads multi-center study of chronic inflammation of the skin that affects women and people of color disproportionately.